Search Within

Roisin Eilish O'Cearbhaill

Formats
  1. Meeting Abstract (128)
  2. Journal Article (125)
  3. Review (9)
  4. Editorial (6)
  5. Book Section (3)
  6. Guidelines (2)
  7. Correspondence (1)
Groups
  1. Department of Medicine (274)
  2. GDMT, Medicine (274)
  3. Gynecologic Medicine Service (274)
  4. Gynecology Disease Management Team (274)
  5. Hematologic Malignancies, Division of (274)
  6. Solid Tumor Oncology Division (274)

More Groups

People
  1. Carol Aghajanian (99)
  2. Alexia Iasonos (75)
  3. Qin Zhou (68)
  4. Rachel Grisham (68)
  5. Dennis Chi (67)
  6. William Tew (66)

More People

Years
  1. 2025 (16)
  2. 2024 (30)
  3. 2023 (43)
  4. 2022 (31)
  5. 2021 (25)
  6. 2020 (41)

More Years

Publications
  1. Gynecologic Oncology (91)
  2. Journal of Clinical Oncology (46)
  3. International Journal of Gynecological Cancer (39)
  4. Annals of Oncology (13)
  5. Gynecologic Oncology Reports (11)
  6. Clinical Cancer Research (9)

More Publications

Publishers
  1. Elsevier B.V. (102)
  2. American Society of Clinical Oncology (49)
  3. Lippincott Williams & Wilkins (40)
  4. Oxford University Press (14)
  5. American Association for Cancer Research (13)
  6. Nature Publishing Group (10)

More Publishers

Results (274)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Gastric-type adenocarcinoma of the cervix: Clinical outcomes and genomic drivers
    Journal Article

    Ehmann, S.; Sassine, D.; Straubhar, A. M.; Praiss, A. M.; Aghajanian, C.; Alektiar, K. M.; Broach, V.; Cadoo, K. A.; Jewell, E. L.; Boroujeni, A. M.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • MOONSTONE/GOG-3032: Interim analysis of a phase 2 study of niraparib plus dostarlimab in patients (pts) with platinum-resistant ovarian cancer (PROC)
    Meeting Abstract

    Randall, L. M.; O'Malley, D. M.; Monk, B. J.; Coleman, R. L.; Gaillard, S.; Adams, S. F.; Duska, L. R.; Cappuccini, F.; Dalton, H.; Holloway, R. W.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Tisotumab vedotin (TV) + pembrolizumab (pembro) in first-line (1L) recurrent or metastatic cervical cancer (r/mCC): Interim results of ENGOT Cx8/GOG 3024/innovaTV 205
    Meeting Abstract

    Lorusso, D.; Vergote, I.; O'Cearbhaill, R. E.; Westermann, A. M.; Banerjee, S. N.; Van Nieuwenhuysen, E.; Iglesias, D. A.; Collins, D. C.; Cibula, D.; Madsen, K.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A phase II trial of IDO-inhibitor, BMS-986205 (IDO), and PD-1 inhibitor, nivolumab (NIVO), in recurrent or persistent endometrial cancer (EC; CA017-056)
    Meeting Abstract

    Kyi, C.; Rubinstein, M. M.; Shah, P.; Zhou, Q.; Iasonos, A.; Liu, Y.; Ramirez, L.; Paroder, V.; Green, A.; Friedman, C. F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Basket study of oral progesterone antagonist onapristone extended release (ONA-XR) in progesterone receptor positive (PR+) recurrent granulosa cell (GCT), low-grade serous ovarian (LGSOC), or endometrioid endometrial cancer (EEC)
    Meeting Abstract

    Grisham, R. N.; Li, K.; Zhou, Q.; Iasonos, A.; Girshman, J.; Shah, P.; Jang, D.; Kyi, C.; Cohen, S. M.; O'Cearbhaill, R. E.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Dysfunctional CD8+T cells in the tumor microenvironment are associated with response to nivolumab in mismatch repair deficient (dMMR) or hypermutated ovarian (OVCA) or endometrial cancer (EC)
    Meeting Abstract

    Friedman, C. F.; Zhou, Q.; Iasonos, A.; Holland, A.; Ramirez, L.; Grisham, R. N.; Guo, R.; Lichtman, S. M.; Kyi, C.; Makker, V.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • COVID-19 in patients with gynecologic cancer: A preliminary report from the COVID-19 and Cancer Consortium (CCC19)
    Meeting Abstract

    Beeghly-Fadiel, A.; Prescott, L. S.; Ruiz-Garcia, E.; Hwang, C.; Heilman, H.; McKay, R. R.; Saliby, R. M.; Lau, S.; Nagaraj, G.; Puc, M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Shared decision making for patients with breast and gynecologic malignancies undergoing chemotherapy associated with persistent alopecia
    Journal Article

    Freites-Martinez, A.; Navitski, A.; Friedman, C. F.; Chan, D.; Goldfarb, S.; Lacouture, M. E.; O'Cearbhaill, R. E.
    Gynecologic Oncology Reports (2022)

    Fulltext@MSK | Save
  • MAPK pathway genetic alterations are associated with prolonged overall survival in low-grade serous ovarian carcinoma
    Journal Article

    Manning-Geist, B.; Gordhandas, S.; Liu, Y. L.; Zhou, Q.; Iasonos, A.; Da Cruz Paula, A.; Mandelker, D.; Long Roche, K.; Zivanovic, O.; Maio, A.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Shared decision making in patients with breast and gynecologic malignancies receiving chemotherapy regimens associated with persistent alopecia
    Meeting Abstract

    Freites-Martinez, A.; O'Cearbhaill, R. E.; Friedman, C. F.
    Journal of the American Academy of Dermatology (2022)

    Fulltext@MSK | Save